How does the October 2026 US Treasury COINS Act NPRM expand 31 CFR Part 850 into biotechnology and AI compute?+
The October 2026 Notice of Proposed Rulemaking under the Comprehensive Outbound Investment Security (COINS) Act adds dual-use biotechnology as a fourth covered sector alongside semiconductors, quantum technologies, and AI. Specifically, it proposes prohibiting U.S. outbound investments into covered foreign persons engaged in unscreened gene synthesis exceeding 1,500 base pairs, biological sequence AI models trained above 10^24 FLOPs, and human genomic databases exceeding 100,000 individuals, while requiring 30-day notifications for high-throughput sequencing (> 20 terabases/run) and dual-use AI models between 10^23 and 10^25 FLOPs.
What are the exact requirements for a US Limited Partner (LP) to qualify for the 31 CFR § 850.501(a)(1)(iii) Safe Harbor?+
To qualify as an Excepted Transaction under 31 CFR § 850.501(a)(1)(iii), a U.S. LP's investment into a pooled fund must be strictly passive (no LPAC approval votes over specific portfolio companies and no GP control rights) and satisfy one of two conditions: (1) the LP's aggregate committed capital does not exceed $2,000,000; or (2) the LP secures a legally binding contractual covenant (via Side Letter or LPA prior to capital deployment) ensuring its capital cannot be used for prohibited or notifiable transactions and segregating its profit/loss waterfall from covered assets.
How does the 50% financial attribution rule under 31 CFR § 850.209(a)(2) apply to Cayman or Singapore holding companies?+
Under 31 CFR § 850.209(a)(2), an entity domiciled outside a country of concern (such as a Cayman Islands, Singapore, or European parent company) is legally designated as a 'covered foreign person' if it holds any equity, voting interest, board seat, or management direction power in a country-of-concern entity engaged in covered national security activities AND derives more than 50.0% of its consolidated revenue, net income, capital expenditure, or operating expense (including R&D compute and laboratory OpEx) from one or more such entities.
How does the October 2026 Senate Clarity Act stalemate impact SEC, CFTC, and EU MiCA compliance for DeFi and stablecoins?+
Because the U.S. Senate rejected the procedural motion on the Clarity Act in October 2026, U.S. market participants remain subject to overlapping SEC and CFTC jurisdiction rather than a statutory digital commodity safe harbor. The SEC enforces Exchange Act Rule 3b-16 against DeFi order-routing interfaces, Section 15(a) against algorithmic liquidity dealers (> $50M), and Section 5 against yield-bearing stablecoin wrappers, while the CFTC enforces CEA Section 2(c)(2)(D) (28-day actual delivery for retail leverage below the $10M ECP floor) and Section 4d FCM rules—whereas EU CASPs operate under a single MiCA Title V passport and EBA 30%/60% EMT bank reserve framework.
